M&A Deal Summary |
|
|---|---|
| Date | 2016-11-14 |
| Target | Oncology Plus |
| Sector | Healthcare Services |
| Buyer(s) | Avella Specialty Pharmacy |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1996 |
| Sector | Life Science |
| Employees | 250 |
Avella Specialty Pharmacy, Inc. is a national specialty pharmacy recognized for its deep clinical knowledge and excellent customer support. The Company serves patients with chronic and complex medical issues in 20 disease states including cancer, hepatitis C, infectious diseases, infertility, and vision impairment. The Company provides mail order fulfillment and compounding services to patients in all 50 states.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 3 |
| Sector: Healthcare Services M&A | 2 of 2 |
| Type: Add-on Acquisition M&A Deals | 3 of 3 |
| State: Florida M&A | 1 of 1 |
| Country: United States M&A | 3 of 3 |
| Year: 2016 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-10-19 |
Advanced Pharma
Houston, Texas, United States Advanced Pharma, Inc. is a provider of compounded sterile preparations to hospitals and health systems nationwide. Advanced Pharma offers compounded formulations across 14 therapeutic classes within its 35,000-square-foot production facility. These preparations are administered by injection, IV or pump in the hospital setting and include pain management medications as well as therapies for dehydration, infection and other serious medical issues. |
Buy | - |
